The bottle promised cellular energy. Eight weeks in, the only thing that has measurably risen is a number in your blood.
That is not a discipline problem. It is an information problem. Nicotinamide riboside is the most-studied NAD+ precursor ever sold. Twenty-five human trials, all agreeing on one result: NR raises blood NAD+, reliably, at every dose tested. What that raised number does to your blood pressure, your blood sugar, your muscles and your brain is a far messier story, and it is the story nobody selling a longevity supplement wants to tell.
Twenty-eight chapters tell it. Trial by trial, dose by dose, with journals and sample sizes attached so you can check every one.
PROVEN. PROMISING. THEORY. NO DATA. Graded on the evidence alone, including the claims that favor NR. A claim that cannot earn a grade does not make the page.
The one number that changes how you read a label. Safety has been tested to 3,000 mg a day and came back clean. Benefit has never been shown above roughly 1,000 mg. Everything priced above that line is sold on the first curve while implying the second.
The real cardiovascular evidence. The nine-point systolic blood pressure drop that made headlines, and the exploratory subgroup it came from. The peripheral artery disease trial where NR moved real walking distance against placebo. The failing heart study that tested it in the exact tissue the biochemistry points to.
Where the story stops. Two rigorous insulin resistance trials came back negative on blood sugar. The longest cognitive trial here missed every primary outcome. Brain fog, the symptom that sells the most supplements and has no diagnostic code, gets its causes ranked by testability.
The mouse that lived longer. One species, one 2016 paper, and the reason every anti aging supplement page still traces back to it. And why it has never been repeated in a human being.
NR vs NMN, on 2026 data. Two head-to-head trials finally ran the comparison in the same people. They disagree, and why tells you more than either result alone. The whole precursor family, niacin, niacinamide, NMN and the IV drip, ranked once by price and again by evidence. Peptide stacks and the combination math nobody runs.
The half of the research nobody ran. Three of the most-cited NR trials enrolled men only. Most mixed-sex trials never reported results by sex. An entire Part covers women, menopause, and the flat dose sized for a body nobody measured, including the one insulin sensitivity result from a trial built around postmenopausal women.
What to actually buy. Side effect rates against placebo. The dose range where the benefit evidence lives, not the range the label calls safe. Three lines on a supplement label that decide whether a bottle is worth the money, five red flags, how proprietary blends hide a dose, and price per effective dose. Where NAD+ sits in your antioxidant defenses, and what it does and does not do for mitochondria, ATP and brain health.
Then test it on yourself. Two weeks to a baseline. Eight weeks to an answer. Twelve weeks to a decision you can defend, with stop rules and an outcome that carries a number.
Written for anyone watching a systolic number climb, tracking cognitive change in older adults, or already comparing longevity supplements. It will not tell you your stack is wrong. It will tell you which parts carry evidence and which carry hope, and it does the same to NR without flinching. If you want certainty, the marketing is free.
Book Four in The Longevity Molecule series. Evidence first, hype never.
Stop paying for a bigger number in your blood. Get the graded answer, then decide.
"synopsis" may belong to another edition of this title.
Seller: California Books, Miami, FL, U.S.A.
Condition: New. Print on Demand. Seller Inventory # I-9798185569191
Seller: PBShop.store UK, Fairford, GLOS, United Kingdom
PAP. Condition: New. New Book. Shipped from UK. Established seller since 2000. Seller Inventory # L2-9798185569191
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Taschenbuch. Condition: Neu. Neuware - The Complete, Evidence-Based Guide to NAD+ and Healthy AgingNinety-four adults walked into a lab with blood pressure creeping past normal. Twelve weeks later, those taking a vitamin B3 derivative had their systolic pressure reduced by roughly nine points. Nine points of systolic blood pressure, at scale, track with a significantly lower risk of cardiovascular decline. But that number came from a subgroup, not the primary outcome. The difference between those two things is the entire reason this book exists.Are you feeling worn down at forty-five instead of thirty Blame stress, bad sleep, or the year, but underneath it all sits a molecule your cells run on: NAD+. As you get older, your NAD+ levels drop. This book investigates the most studied NAD+ precursor of the decade: Nicotinamide Riboside, or NR. It is not a book of miracle claims. It is a complete, evidence-based guide to exactly what happens when you take this longevity molecule.You will discover the exact two-step biological shortcut NR uses to become NAD+ in your cells, and why stressed tissue, like a failing heart, needs it most. You will uncover the truth behind the highly publicized anti-aging mouse studies and learn exactly where the human data currently stands. Every single claim is graded as PROVEN, PROMISING, or THEORY. You will read the actual dose-response data, safety limits up to 3,000 milligrams, and honest clinical results on blood sugar, cardiovascular health, and brain fog.If you are confused by the debate between NR and NMN, this guide delivers clear, head-to-head data on which precursor actually works, along with an honest look at the limitations of the current science. For everyone who has ever raised a biomarker and called it a cure, this book is the second question. Read this definitive guide to understand the currency of life, navigate the hype, and find out exactly what NR can and cannot do for your cellular health. Seller Inventory # 9798185569191
Quantity: 2 available
Seller: CitiRetail, Stevenage, United Kingdom
Paperback. Condition: new. Paperback. Three in the afternoon, and the fog rolls in again. The bottle on your counter promised cellular energy. It has been eight weeks.That is not a discipline problem. It is an information problem. Nicotinamide riboside is the most-studied NAD+ precursor ever sold, and the human trials now run to twenty-five: healthy volunteers, older adults, peripheral artery disease patients, failing hearts. One result survives all of them untouched. NR raises blood NAD+, reliably, every time. What that raised number does to your blood pressure, your blood sugar, your muscles, and your brain is a far messier story, and it is the story almost nobody selling an anti-aging supplement wants to tell you.This book tells it, trial by trial, dose by dose.Every claim carries a grade. No exceptions.PROVEN, PROMISING, or THEORY. Each claim inside is tagged on the strength of the data and nothing else. If a claim cannot earn a tag, it does not make the page.NAD+ is the coenzyme your cells run on, the currency behind ATP production, DNA repair, and the sirtuin proteins tied to the biology of aging. Sirtuins, PARP, and CD38 drain the account. Nicotinamide riboside, a form of vitamin B3, refills it in two enzymatic steps instead of five. That much is settled biochemistry. Whether refilling it fixes anything in a living human body is what twenty-eight chapters are here to answer.What the trials actually foundThe nine-point systolic blood pressure drop that made headlines, and the exploratory subgroup it came from. The peripheral artery disease trial where NR moved a real, placebo-controlled walking distance. The failing-heart study that tested NR in the exact tissue its biochemistry points to. Two rigorous insulin resistance trials that came back negative, and what that means if you take NR for blood sugar. The muscle and mitochondria data in older adults. The blood-brain barrier problem, and what actually gets into your head. Brain fog, the symptom that sells the most supplements and has no diagnostic code. And the mouse lifespan study every longevity marketing page traces back to, with the reason it has never been repeated in humans.The half of the research nobody talks aboutCount the participants in the NAD+ trials and a gap opens up. Three chapters go where the field did not: women, menopause and estrogen, and the flat dose on a bottle sized for a body nobody measured.Dosage, side effects, and what to actually buyFull safety data up to 3,000 mg a day, real side-effect rates against placebo, and the dose range where the benefit evidence lives, which is not the range the label calls safe. The precursor family compared: niacin, niacinamide, NMN, and the IV drip. The antioxidant claim, and where NAD+ genuinely sits in your cell defense system. Peptide stacks and the combination math. Biohacking, healthspan, and the NAD booster industry built on one reliable biomarker. Five red flags on a label, how to price per effective dose, and a twelve-week protocol for running NR as a real experiment on yourself, with stop rules.Written for people who read supplement labels skeptically: anyone watching a blood pressure number climb, tracking age-related cognitive decline, or comparing longevity supplements and tired of being sold certainty the evidence does not support.Book Four in The Longevity Molecule series. The rule never changes: evidence first, hype never.Stop guessing what your NAD+ supplement is doing. Get the graded answer. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Seller Inventory # 9798185569191
Quantity: 1 available